Telemetry Investments, L.L.C. Humanigen, Inc Put Options Transaction History
Telemetry Investments, L.L.C.
- $63.3 Million
- Q4 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HGEN
# of Institutions
4Shares Held
558KCall Options Held
0Put Options Held
0About HUMANIGEN, INC
- Ticker HGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,661,000
- Description
- Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...